Peter Farha
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
-
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 10
- Lung Cancer Research Studies 8
-
- Lung Cancer Treatments and Mutations 6
- Brain Metastases and Treatment 3
- Lung Cancer Diagnosis and Treatment 2
- Metastasis and carcinoma case studies 2
- Co-authors
- Manuel Valdivieso (13 shared papers)Gary Spitzer (12 shared papers)Hari M. Dhingra (10 shared papers)Delia F. Chiuten (10 shared papers)William K. Murphy (8 shared papers)Theera Umsawasdi (10 shared papers)David Carr (6 shared papers)Daniel J. Booser (5 shared papers)
- Journals
- Cancer (3 papers)Journal of Clinical Oncology (2 papers)Journal of Computer Assisted Tomography (1 paper)Journal of Neuro-Oncology (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Peter Farha
14 papers receiving 425 citations
Peers
Comparison fields: 5 of 40
- Oncology 280
- Pulmonary and Respiratory Medicine 240
- Epidemiology 104
- Genetics 21
- Hematology 22
Countries citing papers authored by Peter Farha
This map shows the geographic impact of Peter Farha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Farha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Farha more than expected).
Fields of papers citing papers by Peter Farha
This network shows the impact of papers produced by Peter Farha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Farha. The network helps show where Peter Farha may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Farha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 112 | |
| 2 | 1986 | 75 | |
| 3 | 1985 | 68 | |
| 4 | 1983 | 57 | |
| 5 | 1985 | 37 | |
| 6 | 1984 | 35 | |
| 7 | 1987 | 25 | |
| 8 | 1989 | 19 | |
| 9 | Chemotherapy for advanced adenocarcinoma and squamous cell carcinoma of the lung with etoposide and cisplatin. | 1984 | 14 |
| 10 | 1982 | 8 | |
| 11 | 1982 | 7 | |
| 12 | 1985 | 5 | |
| 13 | I.v. melphalan in carcinoma of the lung: effect of cyclophosphamide priming on hematopoietic toxicity. | 1986 | 4 |
| 14 | Increasing importance of adjuvant surgery in inoperable lung cancer. | 1984 | 2 |
| 15 | 2024 | 0 |
About Peter Farha
Peter Farha is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Epidemiology and Neurology, having authored 15 papers that have together received 468 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (8 papers), Lung Cancer Treatments and Mutations (6 papers), Brain Metastases and Treatment (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Salivary Gland Tumors Diagnosis and Treatment (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Metastasis and carcinoma case studies (2 papers) and Cardiac, Anesthesia and Surgical Outcomes (1 paper). The work is most often cited by research in Oncology (280 citations), Pulmonary and Respiratory Medicine (240 citations), Epidemiology (104 citations), Genetics (21 citations) and Hematology (22 citations). Peter Farha has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Manuel Valdivieso, Gary Spitzer, Hari M. Dhingra, Delia F. Chiuten, William K. Murphy, Theera Umsawasdi, David Carr, Daniel J. Booser, H. Thomas Barkley and Tseng-hui Timothy Chen. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Journal of Computer Assisted Tomography, Journal of Neuro-Oncology and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.